Baughman, R. P., Judson, M., Culver, D., Birring, S., Parambil, J., Zeigler, J. and Lower, E. E. (2021) “Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial”, Sarcoidosis, Vasculitis and Diffuse Lung Disease, 38(3), p. e2021035. doi: 10.36141/svdld.v38i3.11684.